Cargando…

A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8

Metal-organic frameworks (MOFs) are an emerging group of nanomaterials for successful biomedical applications in gene therapy. The most commonly biocompatible MOFs are zinc-based ZIFs, zirconium-based UiOs, and iron-based MILs. However, despite increasing applications, a comparative study to undersc...

Descripción completa

Detalles Bibliográficos
Autores principales: Poddar, A., Pyreddy, S., Polash, S.A., Doherty, C.M., Shukla, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934432/
https://www.ncbi.nlm.nih.gov/pubmed/36824375
http://dx.doi.org/10.1016/j.bbiosy.2022.100065
_version_ 1784889885139664896
author Poddar, A.
Pyreddy, S.
Polash, S.A.
Doherty, C.M.
Shukla, R.
author_facet Poddar, A.
Pyreddy, S.
Polash, S.A.
Doherty, C.M.
Shukla, R.
author_sort Poddar, A.
collection PubMed
description Metal-organic frameworks (MOFs) are an emerging group of nanomaterials for successful biomedical applications in gene therapy. The most commonly biocompatible MOFs are zinc-based ZIFs, zirconium-based UiOs, and iron-based MILs. However, despite increasing applications, a comparative study to underscore the critical factors for determining effective gene delivery by such MOFs is lacking. Herein, we evaluate the potential of UiO-66 and MIL-88B and ZIF-8 for gene therapeutics delivery; revealing the comparative importance of ZIF-8. Cytotoxicity assays proved insufficient for selecting the ideal gene delivery MOF vehicle. Synthesis conditions such as ability of the MOF scaffold to envelop the gene during in-situ synthesis, post-treatment such as washing, and gene loading efficiency proved to be the critical factors in determining the favourable MOF from the material selection perspective. Rapid in-situ synthesis under physiological conditions, successful gene loading, and low concentration requirements favour ZIF MOFs as gene delivery vehicles. Impact on cellular physiology, metabolism, and architecture revealed neutrality of the delivery system; and relative effects on pro-inflammatory and anti-inflammatory cytokines suggest immunomodulatory impact.
format Online
Article
Text
id pubmed-9934432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99344322023-02-22 A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8 Poddar, A. Pyreddy, S. Polash, S.A. Doherty, C.M. Shukla, R. Biomater Biosyst Research Article Metal-organic frameworks (MOFs) are an emerging group of nanomaterials for successful biomedical applications in gene therapy. The most commonly biocompatible MOFs are zinc-based ZIFs, zirconium-based UiOs, and iron-based MILs. However, despite increasing applications, a comparative study to underscore the critical factors for determining effective gene delivery by such MOFs is lacking. Herein, we evaluate the potential of UiO-66 and MIL-88B and ZIF-8 for gene therapeutics delivery; revealing the comparative importance of ZIF-8. Cytotoxicity assays proved insufficient for selecting the ideal gene delivery MOF vehicle. Synthesis conditions such as ability of the MOF scaffold to envelop the gene during in-situ synthesis, post-treatment such as washing, and gene loading efficiency proved to be the critical factors in determining the favourable MOF from the material selection perspective. Rapid in-situ synthesis under physiological conditions, successful gene loading, and low concentration requirements favour ZIF MOFs as gene delivery vehicles. Impact on cellular physiology, metabolism, and architecture revealed neutrality of the delivery system; and relative effects on pro-inflammatory and anti-inflammatory cytokines suggest immunomodulatory impact. Elsevier 2022-10-07 /pmc/articles/PMC9934432/ /pubmed/36824375 http://dx.doi.org/10.1016/j.bbiosy.2022.100065 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Poddar, A.
Pyreddy, S.
Polash, S.A.
Doherty, C.M.
Shukla, R.
A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
title A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
title_full A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
title_fullStr A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
title_full_unstemmed A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
title_short A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
title_sort quest for cytocompatible metal organic frameworks in non-viral gene therapy: relevance of zeolitic imidazolate framework-8
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934432/
https://www.ncbi.nlm.nih.gov/pubmed/36824375
http://dx.doi.org/10.1016/j.bbiosy.2022.100065
work_keys_str_mv AT poddara aquestforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT pyreddys aquestforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT polashsa aquestforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT dohertycm aquestforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT shuklar aquestforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT poddara questforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT pyreddys questforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT polashsa questforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT dohertycm questforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8
AT shuklar questforcytocompatiblemetalorganicframeworksinnonviralgenetherapyrelevanceofzeoliticimidazolateframework8